US › Healthcare

Niki BioSolutions, Inc. (NIKI)

US · Healthcare · Biotechnology

$9.70+1.36%
Last close · 2026-08-04

Latest quarter · ended 2025-12-31

Revenue
$0
Net profit
$-307,495
EPS
$-0.38

Key statistics

Market cap
$8.0M
Forward P/E
0.0
P/B
0.35
Book value
$28.38
EPS (TTM)
$-1.90
52-week high
$44.70
52-week low
$6.00
50-day MA
$8.72
200-day MA
$10.15
Beta
0.17

Shareholding

Insiders
47.24%
Institutions
0.46%

Largest institutional holders

FundStake
Citadel Advisors Llc1.13%
Susquehanna International Group, LLP0.21%
XTX Topco Ltd0.18%
Morgan Stanley - Brokerage Accounts0.16%
Renaissance Technologies Corp0.15%
Advisor Group Holdings, Inc.0.07%
UBS Group AG0.02%
SBI Securities Co Ltd0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Niki BioSolutions, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.